Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LAURION Intercepts of 37.70 g/t Gold over 0.50 m, 6.60 g/t Gold over 1.00 m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

Healthcare Biotechnology
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

Bullboard (CSE:BIOV)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by moneywagonon Apr 10, 2024 12:26pm

RE:RE:New Press Release - BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY

triple amazing thank you BIOV...KEEP WORKING!!! it's a cash cow in the making once we suck and blow through all the red tape...congrats LONGS!!
88
Discussion
Comment by Humaniston Apr 05, 2024 10:19am

RE:New Press Release - BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Thank you biov foranswering my question.. another quick one, is it for sure end of april? you usedthe word anticipate, it doesn't sound for sure. if you are sure ( on or before april 30) please ...more  
118
Discussion
Post by Humaniston Apr 03, 2024 1:20pm

where are the financials? they said end of march!

why no mention about it and still not released? 
78
Post by Magnum2on Mar 08, 2024 3:35pm

CEASE TRADE ORDER...OUCH

I tried to warn ppl, this business requires a ton of cash. Adios BIOV!
134
Post by WinterBaronon Mar 08, 2024 9:13am

CFO NOTIFICATION WAS ALMOST A YEAR AGO.

Why still being used as plausible explanation for failures/delays with financials and related filings? Also curious about how the recent acquisition was financed. Company had negligible cash ($423.00 ...more  
155
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities